ENLIVEX THERAPEUTICS LTD's ticker is ENLV and the CUSIP is M4130Y106. A total of 18 filers reported holding ENLIVEX THERAPEUTICS LTD in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Susquehanna International Group Ltd. | 12,326 | $19,475 | 0.01% |
| Compagnie Lombard Odier SCmA | 65,000 | $104,082 | 0.00% |
| OSAIC HOLDINGS, INC. | 400 | $632 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 838 | $1,324 | 0.00% |
| WELLS FARGO & COMPANY/MN | 8,882 | $14,034 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 10,420 | $16,463 | 0.00% |
| MORGAN STANLEY | 44,156 | $69,766 | 0.00% |
| Citadel Advisors | 1,500 | $2,370 | 0.00% |
| Citadel Advisors | 4,900 | $7,742 | 0.00% |
| Citadel Advisors | 37,683 | $59,539 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 24,200 | $38,236 | 0.00% |
| Steward Partners Investment Advisory, LLC | 3,000 | $4,740 | 0.00% |
| Qube Research & Technologies Ltd | 1 | $2 | 0.00% |
| Red Tortoise LLC | 150 | $237 | 0.00% |
| JPMORGAN CHASE & CO | 1,200 | $1,896 | 0.00% |
| Renaissance Technologies | 58,889 | $93 | 0.00% |
| BARCLAYS PLC | 1,000 | $2 | 0.00% |
| UBS Group AG | 690 | $1,090 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 13,000 | $20,540 | 0.00% |
External links
This page lists ENLIVEX THERAPEUTICS LTD's shareholders in Q3 2023. To view ENLIVEX THERAPEUTICS LTD's shareholder history, click here.